For instance, large-scale sequencing studies of PD patients have identified several risk genes related to lipid metabolism, including GBA1, ASAH1, SMPD1, and SREBF1, which are involved in the synthesis and metabolism of ceramides, sphingomyelin, cholesterol, and other major lipid classes. This evidence concerns the gene SREBF1 and Parkinson disease.